CG
EDIT icon

Cutler Group’s Editas Medicine EDIT Stock Holding History

Cutler Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed – – 4016
2022
Q4 		$0 Hold
100
– – ﹤0.01% 4582
2022
Q3 		$1K Sell
100
-300
-75% -$4.67K ﹤0.01% 4500
2022
Q2 		$4K Hold
400
– – ﹤0.01% 3843
2022
Q1 		$7K Sell
400
-15,015
-97% -$279K ﹤0.01% 3869
2021
Q4 		$409K Buy
15,415
+14,615
+1,827% +$503K 0.02% 852
2021
Q3 		$32K Buy
800
+600
+300% +$32.9K ﹤0.01% 2914
2021
Q2 		$11K Buy
200
+90
+82% +$3.32K ﹤0.01% 3796
2021
Q1 		$4K Sell
110
-300
-73% -$17.1K ﹤0.01% 4493
2020
Q4 		$28K Hold
410
– – ﹤0.01% 2412
2020
Q3 		$11K Sell
410
-190
-32% -$6.19K ﹤0.01% 2902
2020
Q2 		$17K Sell
600
-1,600
-73% -$41.8K ﹤0.01% 2496
2020
Q1 		$43K Sell
2,200
-5,100
-70% -$129K ﹤0.01% 1814
2019
Q4 		$216K Buy
7,300
+500
+7% +$12.5K 0.01% 791
2019
Q3 		$154K Hold
6,800
– – 0.01% 828
2019
Q2 		$168K Buy
6,800
+100
+1% +$2.39K 0.02% 811
2019
Q1 		$163K Buy
6,700
+3,400
+103% +$77K 0.02% 750
2018
Q4 		$75K Buy
3,300
+1,000
+43% +$27.2K 0.01% 1233
2018
Q3 		$73K Sell
2,300
-840
-27% -$27.1K 0.01% 1373
2018
Q2 		$112K Sell
3,140
-8,400
-73% -$297K 0.01% 1079
2018
Q1 		$382K Buy
11,540
+4,120
+56% +$147K 0.03% 513
2017
Q4 		$228K Buy
7,420
+2,169
+41% +$54.6K 0.01% 879
2017
Q3 		$126K Sell
5,251
-12,192
-70% -$232K ﹤0.01% 1475
2017
Q2 		$292K Buy
17,443
+12,313
+240% +$222K 0.01% 1011
2017
Q1 		$114K Buy
+5,130
New +$106K ﹤0.01% 1614

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Cutler Group's EDIT Position: Q1 2023 in Review

Cutler Group sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 100 shares.

Cutler Group first reported a position in EDIT in Q1 2017 and held it in 24 quarters. The position peaked at $409K in Q4 2021. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • Cutler Group reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 100 Editas Medicine shares in Q1 2023.
  • Cutler Group first reported a position in Editas Medicine in Q1 2017 and held it in 24 quarters.
  • Cutler Group's Editas Medicine position peaked at $409K in Q4 2021.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.